- Home
- WTI vs CADL Comparison
WTI vs CADL Comparison
Compare WTI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTI
- CADL
- Stock Information
- Founded
- WTI 1983
- CADL 1999
- Country
- WTI United States
- CADL United States
- Employees
- WTI N/A
- CADL N/A
- Industry
- WTI Oil & Gas Production
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- WTI Energy
- CADL Health Care
- Exchange
- WTI Nasdaq
- CADL Nasdaq
- Market Cap
- WTI 276.1M
- CADL 252.0M
- IPO Year
- WTI 2005
- CADL 2021
- Fundamental
- Price
- WTI $1.81
- CADL $5.12
- Analyst Decision
- WTI
- CADL Strong Buy
- Analyst Count
- WTI 0
- CADL 5
- Target Price
- WTI N/A
- CADL $21.40
- AVG Volume (30 Days)
- WTI 3.9M
- CADL 923.9K
- Earning Date
- WTI 08-05-2025
- CADL 08-12-2025
- Dividend Yield
- WTI 2.26%
- CADL N/A
- EPS Growth
- WTI N/A
- CADL N/A
- EPS
- WTI N/A
- CADL N/A
- Revenue
- WTI $514,341,000.00
- CADL N/A
- Revenue This Year
- WTI $3.30
- CADL N/A
- Revenue Next Year
- WTI $3.29
- CADL N/A
- P/E Ratio
- WTI N/A
- CADL N/A
- Revenue Growth
- WTI N/A
- CADL N/A
- 52 Week Low
- WTI $1.09
- CADL $3.79
- 52 Week High
- WTI $2.84
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- WTI 50.69
- CADL 48.58
- Support Level
- WTI $1.62
- CADL $4.73
- Resistance Level
- WTI $1.77
- CADL $5.24
- Average True Range (ATR)
- WTI 0.18
- CADL 0.29
- MACD
- WTI -0.05
- CADL 0.00
- Stochastic Oscillator
- WTI 17.24
- CADL 64.92
About WTI W&T Offshore Inc.
W&T Offshore Inc is an oil and gas exploration and production company. The company's exploration operations are focused in the Gulf of Mexico, where it drills for oil and gas. The company engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of company's revenue, with natural gas accounting for a much smaller portion.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.